IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

List of Oncology Medication For

Arthritis

Rheumatology is a branch of medicine devoted to the evaluation, diagnosis, and management of musculoskeletal disorders or other connective diseases, including arthritis and sort tissue lesions.

If Rheumatology Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Kineret (anakinra) for injection

Kineret (anakinra) – Rheumatoid Arthritis (RA) Therapy in India

Kineret (anakinra) is indicated for treating moderately to severely active Rheumatoid Arthritis (RA) in adults failing other DMARDs, and for rare autoinflammatory conditions like Cryopyrin-Associated Periodic Syndromes (CAPS), including NOMID, and Deficiency of Interleukin-1 Receptor Antagonist (DIRA), plus Still’s Disease (SJIA/AOSD) in specific age groups, working by blocking inflammation-causing interleukin-1. It’s an immunosuppressant that blocks immune chemical messengers.

Brand Name: Kineret
Generic Name: anakinra
Strength: Injection: 100 mg/0.67 mL solution in a single-use prefilled syringe for
subcutaneous injection. Graduated syringe allows for doses between 20 mg and 100 mg.
Manufacturer: Swedish Orphan Biovitrum AB (publ)
Approved By: EMA, USFDA

Source Details: Patient Information.

Get access to Kineret in India for Rheumatoid Arthritis (RA) treatment through Named-Patient Import in India.

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Kineret (anakinra) for injection for personal use. For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

read more

OTULFI (ustekinumab-aauz) injection

OTULFI is a human interleukin-12 and -23 antagonist indicated for the treatment of:
Adult patients with:
• moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy
• active psoriatic arthritis (PsA).
• moderately to severely active Crohn’s disease (CD).
• moderately to severely active ulcerative colitis.
Pediatric patients 6 years and older with:
• moderate to severe plaque psoriasis, who are candidates for phototherapy or systemic therapy.
• active psoriatic arthritis (PsA).

Brand Name: OTULFI
Generic Name: ustekinumab-aauz injection
Strength: Subcutaneous Injection 
• Injection: 45 mg/0.5 mL or 90 mg/mL solution in a single-dose prefilled syringe
Intravenous Infusion 
• Injection: 130 mg/26 mL (5 mg/mL) solution in a single-dose vial
Manufacturer: Fresenius Kabi USA, LLC
Approved By: EMA, USFDA

Source Details: Patient Information.

Get access OTULFI for aTTP Treatment through Named-Patient Import in India

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to OTULFI (ustekinumab-aauz) injection for personal use. For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

read more

RINVOQ (upadacitinib) tablets

RINVOQ (upadacitinib) extended-release tablets, for oral use Initial U.S. Approval: 2019

RINVOQ is a prescription medicine used to treat: Adults with moderate to severe rheumatoid arthritis (RA) when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated.

Brand Name: RINVOQ
Generic Name: upadacitinib
Strength: • Extended-release tablets: 15 mg, 30 mg, and 45 mg
Manufacturer: AbbVie Inc
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “RINVOQ (upadacitinib) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for RINVOQ (upadacitinib) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

read more

Rituximab-abbs Injection

,

rituximab-abbs injection
for intravenous use Initial U.S. Approval: 2018

Truxima (rituximab) is a medication used for the treatment of follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL); chronic lymphocytic leukemia (CLL); severe active rheumatoid arthritis and granulomatosis with polyangiitis and microscopic polyangiitis.

Facts about rituximab-abbs injection

Disease Indications-Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis , Polyangiitis
Manufacturer-Celltrion Healthcare Hungary Kft, Teva Pharmaceuticals
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “Rituximab-abbs Injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

read more

Safinamide Tablets

safinamide tablets
for oral use Initial U.S. Approval: 2017

XADAGO is a monoamine oxidase type B (MAO-B) inhibitor indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes

Facts about safinamide tablets

Approval Date:  2017
Proprietary Name:  XADAGO (safinamide) tablets
Active Ingredient(s):  safinamide
FDA-approved use:
Dosage Form:  Tablets: 50 mg and 100 mg
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: US WorldMeds, LLC,
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “safinamide tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

read more

Sarilumab Injection

Sarilumab injection, for subcutaneous use InitialU.S.Approval:2017

Generic Name – Kevzara (Sarilumab)
Medicine Type – Injection / Intravenous
Manufacturer Name – Regenore, Sanofi
Approval Year – 2017
Approved by – US Food and Drug Administration (FDA)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import sarilumab injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

read more

SELARSDI (ustekinumab-aekn) Injection

, , ,

Brand Name: SELARSDI. Generic Name: (ustekinumab-aekn). It is used to treat plaque psoriasis (PsO), psoriatic arthritis (PsA), Crohn’s disease (CD), ulcerative colitis(UC).

SELARSDI is a human interleukin-12 and -23 antagonist indicated for the treatment of:
Adult patients with:
• moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy.
• active psoriatic arthritis (PsA).
• moderately to severely active Crohn’s disease (CD).
• moderately to severely active ulcerative colitis.

Brand Name: SELARSDI
Generic Name: ustekinumab-aekn
Strength: • Subcutaneous Injection
Injection: 45 mg/0.5 mL or 90 mg/mL solution in a single-dose prefilled syringe
• Intravenous Infusion
Injection: 130 mg/26 mL (5 mg/mL) solution in a single-dose vial
Manufacturer: Teva Pharmaceuticals
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “SELARSDI (ustekinumab-aekn) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more

SIMLANDI (adalimumab-ryvk ) Injection

, , ,

Brand Name: SIMLANDI. Generic Name: (adalimumab-ryvk). It is used to treat plaque psoriasis, Crohn’s disease, ulcerative colitis, rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, hidradenitis suppurativa, and uveitis.

SIMLANDI (adalimumab-ryvk ) Injection is a drug used to treat plaque psoriasis, Crohn’s disease, ulcerative colitis, rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, hidradenitis suppurativa, and uveitis in certain patients.

Brand Name: SIMLANDI
Generic Name: adalimumab-ryvk
Strength: • Injection: 40 mg/0.4 mL single-dose autoinjector
Manufacturer: Teva Pharmaceuticals
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “SIMLANDI (adalimumab-ryvk ) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more

TALTZ (ixekizumab) injection

TALTZ (ixekizumab) – for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA) Therapy in India

TALTZ® is a humanized interleukin-17A antagonist indicated for the treatment of: • patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. • adults with active psoriatic arthritis. • adults with active ankylosing spondylitis.

Brand Name: TALTZ
Generic Name: ixekizumab
Strength: Injection:
• 80 mg/mL solution in a single-dose prefilled autoinjector
• 80 mg/mL solution in a single-dose prefilled syringe
• 40 mg/0.5 mL solution in a single-dose prefilled syringe
• 20 mg/0.25 mL solution in a single-dose prefilled syringe
Manufacturer: Eli Lilly and Company
Approved By: EMA, USFDA

Source Details: Patient Information

Access TALTZ for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA)

Ixekizumab, sold under the brand name TALTZ, is available in India. Patients can access this medicine for personal use through authorized channels. IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors. To proceed, the applicant must submit an application with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 |  Mr. Neeraj: +91 9811 747 774.

read more

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in 
urgent@indianpharmanetwork.co.in